Northstar is a Canadian waste to value technology company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar developed and owns a proprietary design process for taking discarded asphalt shingles, otherwise destined for already over-crowded landfills, and extracts the liquid asphalt for use in new hot mix asphalt shingle manufacturing and asphalt flat roof systems while also extracting aggregate and fiber for use in construction products and other industrial applications. Focused on the circular economy, Northstar plans to reprocess used or defective asphalt shingle waste back into its three primary components for reuse/resale with its first commercial scale up facility in Calgary, Alberta. As an emerging innovator in sustainable processing, Northstar's mission aims at leading the recovery and reprocessing of asphalt shingles in North America that would otherwise be sent to landfill addressing numerous stakeholder objectives.

Frontera Energy Corporation is a Canadian public company involved in the exploration, development, production, transportation, storage and sale of oil and natural gas in South America, including related investments in both upstream and midstream facilities. The Company has a diversified portfolio of assets with interests in 22 exploration and production blocks in Colombia, Ecuador and Guyana, and pipeline and port facilities in Colombia. Frontera is committed to conducting business safely and in a socially, environmentally and ethically responsible manner.

The Dotz solution combines self-developed Graphene and Carbon based materials with cutting-edge detectors, mobile app, and cloud software to offer user-friendly and robust product authentication, traceability and anti-alteration for a range of industries and applications.

Ethema Health Corporation (OTCQB: GRST), together with its subsidiaries, operates in the behavioral healthcare space specifically in the treatment of substance use disorders. With a seasoned management team, Ethema strives to develop world-class “centers of excellence” in addiction treatment for adults. The Company currently operates in West Palm Beach, Florida.

The Dotz solution combines self-developed Graphene and Carbon based materials with cutting-edge detectors, mobile app, and cloud software to offer user-friendly and robust product authentication, traceability and anti-alteration for a range of industries and applications.

Auxly Cannabis Group Inc. (OTCQB: CBWTF | TSX: XLY)

We are a group of cannabis enthusiasts, entrepreneurs, CPG professionals, researchers and scientists with a shared belief in quality, executional excellence, continual innovation and building authentic connections with consumers.

DarkPulse, Inc. (OTCQB: DPLS)

DarkPulse, Inc. uses advanced laser-based monitoring systems to provide rapid and accurate monitoring of temperatures, strains, and stresses. The Company’s technology excels when applied to live, dynamic critical infrastructure and structural monitoring, including pipeline monitoring, perimeter and structural surveillance, aircraft structural components and mining safety. The Company’s fiber-based monitoring systems can assist markets that are not currently served, and its unique technology covers extended areas and any event that is translated into the detection of a change in strain or temperature. In addition to the Company’s ongoing efforts with respect to the marketing and sales of its technology products and services to its customers, the Company also continues to explore potential strategic alliances through joint venture and licensing opportunities to further expand its global market position. For more information, visit www.DarkPulse.com.

Nature's Miracle Holding Inc. (OTCQB: NMHI)

Nature's Miracle (OTCQB: NMHI) is a U.S.-based smart agriculture technology company providing turnkey vertical farming systems and controlled-environment solutions. The company integrates AI-driven monitoring, automation, and sustainable agriculture technologies to enhance yield efficiency and environmental impact across global markets.

Cyberloq Technologies Inc (MFA)

CyberloQ is a MFA ( Multi Factor Authentication ) protocol technology that is offered to institutional clients in order to combat fraudulent transactions and unauthorized access to customer accounts and or any digital asset. Through the use of a customer's smart-phone, CyberloQ uses a multi-factor authentication system to control access to a bank card, transaction type or amount, website, database or digital service. The mobile applications for CyberloQ have been built, and have been successfully integrated into the banking ecosystem. The Company has also updated the entire infrastructure, UI/UX and streamlined the deliverable services per strategic partnerships with clients in multiple channels in order to increase the scalability of the original platform.

Xtreme One Entertainment, Inc. ($XONI)

Founded in 1995 as a diversified holding company, http://www.xtremeone.com/Xtreme One Entertainment, Inc. (OTC: XONI) is focused on media, entertainment, live sports, and event marketing. The Company, through its wholly owned subsidiary, XFC Global, Inc. (XFC), is the licensee of all the brands and intellectual property formerly produced and promoted by Xtreme Fighting Championships Inc. worldwide, including over 50 televised professional MMA events spanning hundreds of fights in the U.S. and Latin America produced since 2006. Xtreme One acquired XFC Global in 2023, and under the direction of the Company's world-class Board and management team, the Company has produced five televised pro MMA events viewed by millions of fans. XFC fights are streamed live on beIN Sports, BAND, Pay Per View, Triller TV, the American Forces Network and a growing number of media platforms.

Telo Genomics Corp.

Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team's considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers. The benefits of our proprietary technology have been substantiated in over 150 peer reviewed publications and in 25 clinical studies involving more than 3,000 patients with multiple cancers and Alzheimer's disease. Our lead application, TELO-MM is being developed to provide important, actionable information to medical professionals in the treatment of Multiple Myeloma, a deadly form of blood cancer. For more information, please visit www.telodx.com.